Prostaglandin E2 mediates phosphorylation and down-regulation of the tuberous sclerosis-2 tumor suppressor (tuberin) in human endometrial adenocarcinoma cells via the Akt signaling pathway

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 12, 2004, Pages 6112-6118

  Sales, Kurt J ^a   Battersby, Sharon ^a   Williams, Alistair R W ^b   Anderson, Richard A ^a   Jabbour, Henry N ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; PROSTAGLANDIN E2; PROTEIN KINASE B; TUBERIN; WORTMANNIN; AKT1 PROTEIN, HUMAN; ONCOPROTEIN; PROTEIN SERINE THREONINE KINASE; REPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ADENOCARCINOMA; AGED; DOWN REGULATION; DRUG EFFECT; ENDOMETRIUM; ENDOMETRIUM TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ADENOCARCINOMA; AGED; BLOTTING, WESTERN; CELL LINE, TUMOR; DINOPROSTONE; DOWN-REGULATION; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; REPRESSOR PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; TUMOR SUPPRESSOR PROTEINS;

EID: 10344242948     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-0892     Document Type: Article

References (37)

1. Gordon MD, Ireland K 1994 Pathology of hyperplasia and carcinoma of the endometrium. Semin Oncol 21:64-70
2. Mant JW, Vessey MP 1994 Ovarian and endometrial cancers. Cancer Surv 20:287-307
3. Wingo PA, Tong T, Bolden S 1995 Cancer statistics, 1995. Cancer J Clin 45:8-30
4. Sales KJ, Jabbour HN 2003 Cyclooxygenase enzymes and prostaglandins in reproductive tract physiology and pathology. Prostaglandins Other Lipid Mediat 71:97-117
5. Chandrasekharan NV, Dai H, Roos KL, Evanson NK, Tomsik J, Elton TS, Simmons DL 2002 COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: cloning, structure, and expression. Proc Natl Acad Sci USA 99:13926-13931
6. 2 in endometrial adenocarcinoma: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. Br J Cancer 85:1023-1031
7. 2 synthesis are up-regulated in carcinomas of the cervix: a possible autocrine/paracrine regulation of neoplastic cell function via EP2/EP4 receptors. J Clin Endocrinol Metab 86:2243-2249
8. Yoshimatsu K, Golijanin D, Paty PB, Soslow RA, Jakobsson PJ, DeLellis RA, Subbaramaiah K, Dannenberg AJ 2001 Inducible microsomal prostaglandin E synthase is overexpressed in colorectal adenomas and cancer. Clin Cancer Res 7:3971-3976
9. Coleman RA, Smith WL, Narumiya S 1994 International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 46:205-229
10. Sheng H, Shao J, Washington MK, DuBois RN 2001 Prostaglandin E2 increases growth and motility of colorectal carcinoma cells. J Biol Chem 276:18075-18081
11. Tsujii M, Kawano S, DuBois RN 1997 Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. Proc Natl Acad Sci USA 94:3336-3340
12. Tsujii M, Kawano S, Tsuji S, Sawaoka H, Hori M, DuBois RN 1998 Cyclooxygenase regulates angiogenesis induced by colon cancer cells. Cell 93:705-716
13. Subbaramaiah K, Altorki N, Chung WJ, Mestre JR, Sampat A, Dannenberg AJ 1999 Inhibition of cyclooxygenase-2 gene expression by p53. J Biol Chem 274:10911-10915
14. Okamoto T, Hara A, Hino O 2003 Down-regulation of cyclooxygenase-2 expression but up-regularion of cyclooxygenase-1 in renal carcinomas of the Eker (TSC2 gene mutant) rat model. Cancer Sci 94:22-25
15. Kobayashi T, Minowa O, Sugitani Y, Takai S, Mitani H, Kobayashi E, Noda T, Hino O 2001 A germ-line Tsc1 mutation causes tumor development and embryonic lethality that are similar, but not identical to, those caused by Tsc2 mutation in mice. Proc Natl Acad Sci USA 98:8762-8767
16. Kobayashi T, Minowa O, Kuno J, Mitani H, Hino O, Noda T 1999 Renal carcinogenesis, hepatic hemangiomatosis, and embryonic lethality caused by a germ-line Tsc2 mutation in mice. Cancer Res 59:1206-1211
17. Kobayashi T, Mitani H, Takahashi R-I, Hirabayashi M, Ueda M, Tamura H, Hino O 1997 Transgenic rescue from embryonic lethality and renal carcinogenesis in the Eker rat model by introduction of a wild-type Tsc2 gene. Proc Natl Acad Sci USA 94:3990-3993
18. Krymskaya VP 2003 Tumour suppressors hamartin and tuberin: intracellular signalling. Cell Signal 15:729-739
19. Nellist M, Verhaaf B, Goedbloed MA, Reuser AJ, van den Ouweland AM, Halley DJ 2001 TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex. Hum Mol Genet 10:2889-2898
20. Aicher LD, Campbell JS, Yeung RS 2001 Tuberin phosphorylation regulates its interaction with hamartin. Two proteins involved in tuberous sclerosis. J Biol Chem 276:21017-21021
21. Dan HC, Sun M, Yang L, Feldman RI, Sui XM, Ou CC, Nellist M, Yeung RS, Halley DJ, Nicosia SV, Pledger WJ, Cheng JQ 2002 Phosphatidylinositol 3-kinase/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J Biol Chem 277:35364-35370
22. Noyes RW, Hertig AT, Rock J 1950 Dating the endometrial biopsy. Fertil Steril 1:3-25
23. Norton AJ, Jordan S, Yeomans P 1994 Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues. J Pathol 173:371-379
24. Plas DR, Thompson CB 2003 Akt activation promotes degradation of tuberin and FOXO3a via the proteasome. J Biol Chem 278:12361-12366
25. Smith SK, Abel MH, Kelly RW, Baird DT 1981 Prostaglandin synthesis in the endometrium of women with ovular dysfunctional uterine bleeding. Br J Obstet Gynaecol 88:434-442
26. Sales KJ, Katz AA, Howard B, Soeters RP, Millar RP, Jabbour HN 2002 Cyclooxygenase-1 is up-regulated in cervical carcinomas: autocrine/paracrine regulation of cyclooxygenase-2, PGE receptors and angiogenic factors by cyclooxygenase-1. Cancer Res 62:424-432
27. Govindarajan B, Mizesko MC, Miller MS, Onda H, Nunnelly M, Casper K, Brat D, Cohen C, Arbiser JL 2003 Tuberous sclerosis-associated neoplasms express activated p42/44 mitogen-activated protein (MAP) kinase, and inhibition of MAP kinase signaling results in decreased in vivo tumor growth. Clin Cancer Res 9:3469-3475
28. Hunter DS, Klotzbucher M, Kugoh H, Cai SL, Mullen JP, Manfioletti G, Fuhrman U, Walker CL 2002 Aberrant expression of HMGA2 in uterine leiomyoma associated with loss of TSC2 tumor suppressor gene function. Cancer Res 62:3766-3772
29. 2 receptor EP2-dependent angiogenesis in APC Δ716 mouse intestinal polyps. Cancer Res 62:506-511
30. Tsujii M, DuBois RN 1995 Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2. Cell 83:493-501
31. 2 and EP2/EP4 receptors in human nonpregnant endometrium across the menstrual cycle. J Clin Endocrinol Metab 86:4453-4459
32. Hengstschlager M, Rodman DM, Miloloza A, Hengstschlager-Ottnad E, Rosner M, Kubista M 2001 Tuberous sclerosis gene products in proliferation control. Mutat Res 488:233-239
33. Soucek T, Holzl G, Bernaschek G, Hengstschlager M 1998 A role of the tuberous sclerosis gene-2 product during neuronal differentiation. Oncogene 16:2197-2204
34. Potter CJ, Pedraza LG, Xu T 2002 Akt regulates growth by directly phosphorylating Tsc2. Nat Cell Biol 4:658-665
35. Pasumarthi KB, Nakajima H, Nakajima HO, Jing S, Field LJ 2000 Enhanced cardiomyocyte DNA synthesis during myocardial hypertrophy in mice expressing a modified TSC2 transgene. Circ Res 86:1069-1077
36. Fujino H, Regan JW 2003 Prostanoid receptors and phosphatidylinositol 3-kinase: a pathway to cancer? Trends Pharmacol Sci 24:335-340
37. Hawcroft G, Gardner SH, Hull MA 2004 Expression of prostaglandin D2 receptors DP1 and DP2 by human colorectal cancer cells. Cancer Lett 210:81-84